Skip to content

Development and efficacy evaluation of a lipid-lowering and hair fixing solution for treating androgenic alopecia

Development and efficacy evaluation of a lipid-lowering and hair fixing solution for treating androgenic alopecia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001510
Enrollment
Unknown
Registered
2025-07-29
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic Alopecia

Interventions

Observers:Remove fat and fix hair fluid 1ml/time once in the morning and once in the evening/day. Instruct the patient to spray it on the hair loss area when it is dry and give appropriate massage.
control group:Minoxidil, 1ml/time, once in the morning and once in the evening/day, instruct the patient to spray it on the hair loss area when it is dry, and give appropriate massage

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the Western diagnostic criteria for androgenetic alopecia; (2) Those who meet the diagnostic criteria for traditional Chinese medicine damp heat steaming syndrome in androgenetic alopecia; (3) Gender is not required, age range is 18-65 years old, including 18 and 65 years old; (4) Have not received any other treatment related to this disease in the three months prior to treatment; (5) Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet any of the inclusion criteria mentioned above; (2) Pregnant or lactating women; (3) Merge other serious diseases such as severe cardiovascular and cerebrovascular diseases; Psychiatric patients; Patients with consciousness disorders or unclear consciousness. (4) Individuals who are allergic to the medication used in this experiment; (5) Individuals with congenital baldness scarred baldness lupus baldness syphilitic baldness alopecia areata and trichotillomania; (6) Individuals with acquired baldness caused by other diseases and medications; (7) Patients with scalp trauma and infection.

Design outcomes

Primary

MeasureTime frame
hair;

Countries

China

Contacts

Public ContactLi Mao

The First Affiliated Hospital of Chengdu Medical College

552323002@qq.com18512855224

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026